Stock Research for ATTBF


Featured Broker: Ally Invest

Get the due diligence for another stock.


ATTBF Stock Chart & Research Data

The ATTBF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATTBF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ATTBF Due diligence Resources & Stock Charts

The ATTBF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATTBF Detailed Price Forecast - CNN Money CNN View ATTBF Detailed Summary - Google Finance
Yahoo View ATTBF Detailed Summary - Yahoo! Finance Zacks View ATTBF Stock Research & Analysis -

Stock Analysis

TradeIdeas View ATTBF Trends & Analysis - Trade-Ideas Barrons View ATTBF Major Holders - Barrons
NASDAQ View ATTBF Call Transcripts - NASDAQ Seeking View ATTBF Breaking News & Analysis - Seeking Alpha
Spotlight View ATTBF Annual Report - OTC Report View ATTBF OTC Short Report -
TradeKing View ATTBF Fundamentals - TradeKing Charts View ATTBF SEC Filings - Bar Chart
WSJ View Historical Prices for ATTBF - The WSJ Morningstar View Performance/Total Return for ATTBF - Morningstar
MarketWatch View the Analyst Estimates for ATTBF - MarketWatch CNBC View the Earnings History for ATTBF - CNBC
StockMarketWatch View the ATTBF Earnings - StockMarketWatch MacroAxis View ATTBF Buy or Sell Recommendations - MacroAxis
Bullish View the ATTBF Bullish Patterns - American Bulls Short Pains View ATTBF Short Pain Metrics -

Social Media Mentions

StockTwits View ATTBF Stock Mentions - StockTwits PennyStocks View ATTBF Stock Mentions - PennyStockTweets
Twitter View ATTBF Stock Mentions - Twitter Invest Hub View ATTBF Investment Forum News - Investor Hub
Yahoo View ATTBF Stock Mentions - Yahoo! Message Board Seeking Alpha View ATTBF Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ATTBF - Insider Cow View Insider Transactions for ATTBF - Insider Cow
CNBC View ATTBF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATTBF - OTC Markets
Yahoo View Insider Transactions for ATTBF - Yahoo! Finance NASDAQ View Institutional Holdings for ATTBF - NASDAQ

Stock Charts

FinViz View ATTBF Stock Insight & Charts - StockCharts View ATTBF Investment Charts -
BarChart View ATTBF Stock Overview & Charts - BarChart Trading View View ATTBF User Generated Charts - Trading View

Latest Financial News for ATTBF

Abattis Provides Corporate Updates
Posted on Wednesday July 11, 2018

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to provide the following corporate updates. Abattis has completed a non-brokered private placement for gross proceeds of $2.25 million (the “Proceeds”) through the issuance of 13,235,294 common shares of the Company priced at $0.17 per share. The Company anticipates that the Proceeds will be used to organically grow its existing downstream service division and for general working capital purposes.

Abattis Enters Into Definitive Agreement to Launch New Cannabis Lab in Ontario
Posted on Thursday June 28, 2018

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that it has entered into a definitive investment agreement dated June 27, 2018 (the “Agreement”) with XLABS Therapeutics (ONT) Inc. (“XLABS”) to launch a new Cannabis laboratory in Belleville, Ontario (the “Laboratory”). The Laboratory will be designed to service Ontario’s growing cannabis sector, which currently numbers 59 licensed producers (“LPs”). “This is another very significant milestone for Abattis,” stated Rob Abenante, President and CEO of Abattis.

Abattis and BLOCKStrain Execute Letter of Intent for Product Integration and Strategic Partnership
Posted on Tuesday June 05, 2018

OTC:ATTBF) ("Abattis") and BLOCKSTRAIN TECHNOLOGY CORP. ("BLOCKStrain") (TSXV: DNAX.V) are pleased to announce that they have signed a letter of intent (the "LOI") to integrate BLOCKStrain's proprietary technology into Abattis's  product and services ecosystem. Through their collaboration, the parties hope to enable Abattis clients to instantly arrange for sales, shipping, testing and analysis of Abattis products and give clients comprehensive visibility over such products over their entire lifecycles. Abattis and BLOCKStrain also intend to explore development and integration opportunities to expand on Abattis's current life sciences and biotechnology services offerings.

Abattis and Vergence Naturals Launch New Marketing Campaign
Posted on Thursday May 24, 2018

VANCOUVER, British Columbia, May 24, 2018-- Abattis Bioceuticals Corp. and its wholly-owned subsidiary, Vergence Naturals Ltd., have launched their“ Live. ”marketing campaign to build awareness for their ...

Enter a stock symbol to view the stock details.